• Home
  • Biotechnology and Medical Research (TRBC)

Tag : Biotechnology and Medical Research (TRBC)

Science

Novacyt biotech company says winning race for high-speed virus test

headline
PARIS (HeadlineNews) – Franco-British biotech company Novacyt says it can offer a coronavirus test that is faster than rival methods by focusing on a narrow
Health

Novartis, Merck and Allergan join those raising U.S. drug prices for 2020

headline
NEW YORK (HeadlineNews) – Novartis AG, Merck & Co Inc and Allergan Plc were among companies that raised U.S. prices on more than 100 prescription
Science

China plans to issue biosafety certificates to domestic GM soybean, corn

headline
BEIJING (HeadlineNews) – China’s agriculture ministry said on Monday it plans to issue biosafety certificates to a domestically grown, genetically modified (GM) soybean crop and
Health

Novartis plans Zolgensma giveaways as some fear ‘health lottery’

headline
ZURICH (HeadlineNews) – Novartis aims to give away 100 doses of its $2.1 million-per-patient Zolgensma for spinal muscular atrophy (SMA) in 2020 in a free-drug
Health

Bristol-Myers wins $752 million in U.S. patent case against Gilead

headline
FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage, near Agen, France March 29,
Tech

South Korea jails three Samsung Electronics executives over evidence destroyed in probe of alleged fraud

headline
SEOUL (HeadlineNews) – A South Korean court on Monday jailed three executives of Samsung Electronics (005930.KS) for their role in a plot that included burying
Science

Half of lymphoma patients alive three years after Gilead cell therapy treatment: study

headline
(HeadlineNews) – Nearly half of lymphoma patients treated with Gilead Sciences Inc’s Yescarta were alive at least three years after a one-time infusion of the
Science

Bristol-Myers reports positive data on cancer treatment acquired in Celgene deal

headline
(HeadlineNews) – Bristol-Myers Squibb Co on Saturday said that an experimental cancer therapy it acquired as part of its $74 billion deal for Celgene Corp

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More